On July 7, 2026, the Securities and Exchange Commission (the “SEC”) published its 2026 Unified Agenda of Regulatory and Deregulatory Actions (the ...
ImmuneSelect is Virax's commercially available research-use-only ("RUO") immune profiling product line and is distinct from ViraxImmune™, the Company's in-development diagnostic platform currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results